Literature DB >> 3826893

Role of HLA-DR antigens in Japanese patients with sarcoidosis.

H Kunikane, S Abe, Y Tsuneta, T Nakayama, Y Tajima, J Misonou, A Wakisaka, M Aizawa, Y Kawakami.   

Abstract

Fifty-three Japanese patients with sarcoidosis were tested for HLA-A,B,C, DR, and DQ antigens in order to investigate immunogenetic mechanisms in the pathogenesis of sarcoidosis. All of the patients had abnormal shadows on their chest radiographs, and all had histologically confirmed sarcoidosis. Groups of 60 and 57 unrelated Japanese served as control subjects for HLA-A,B,C and HLA-D region antigens, respectively. The frequency of HLA-DRw52 was 79.2% (42 of 53) in the patient group compared with 50.9% (29 of 57) in the control group, and the difference was significant (chi 2 = 9.66, p less than 0.005, pc less than 0.05, relative risk = 3.69). On the other hand, no significant association was found with HLA-A,B,C antigens. When various clinical features of the patients were taken into account, there was a tendency for the frequency of DRw52 to be lower in the patients who were in an advanced stage or who had resisted treatment with steroids. Furthermore, 31 of the 32 patients without ophthalmic involvement were DRw52-positive, which was highly significant (96.9% as compared with 50.9% of the control group; chi 2 = 19.74, p less than 0.001, pc less than 0.01, relative risk = 29.93), whereas the frequency of DRw52 in the patients with ophthalmic involvement was almost the same as in the control group. These results suggest that HLA-DR antigens play a significant role in the pathogenesis of sarcoidosis, and there may be a heterogeneity in the clinical entity of sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3826893     DOI: 10.1164/arrd.1987.135.3.688

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  5 in total

1.  Analysis of restriction fragment length polymorphism for the HLA-DR gene in Japanese patients with sarcoidosis.

Authors:  H Kunikane; S Abe; E Yamaguchi; J M Aparicio; A Wakisaka; T Yoshiki; Y Kawakami
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

2.  HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

Authors:  Milton D Rossman; Bruce Thompson; Margaret Frederick; Mary Maliarik; Michael C Iannuzzi; Benjamin A Rybicki; Janardan P Pandey; Lee S Newman; Eleni Magira; Bojana Beznik-Cizman; Dimitri Monos
Journal:  Am J Hum Genet       Date:  2003-08-20       Impact factor: 11.025

3.  Clinical features of sarcoidosis in relation to HLA distribution and HLA-DRB3 genotyping by PCR-RFLP.

Authors:  M Ishihara; T Ishida; N Mizuki; H Inoko; H Ando; S Ohno
Journal:  Br J Ophthalmol       Date:  1995-04       Impact factor: 4.638

4.  Lack of association between IL10 polymorphisms and sarcoidosis in Japanese patients.

Authors:  Kenichi Sakuyama; Akira Meguro; Masao Ota; Mami Ishihara; Riyo Uemoto; Haruyasu Ito; Eiichi Okada; Kenichi Namba; Nobuyoshi Kitaichi; Shin-ichiro Morimoto; Toshikatsu Kaburaki; Yasutaka Ando; Shinobu Takenaka; Takenosuke Yuasa; Shigeaki Ohno; Hidetoshi Inoko; Nobuhisa Mizuki
Journal:  Mol Vis       Date:  2012-01-25       Impact factor: 2.367

5.  Association of serum TNF-α, IL-8 and free light chain with HLA-DR B alleles expression in pulmonary and extra-pulmonary sarcoidosis.

Authors:  Esmaeil Mortaz; Hale Abdoli Sereshki; Atefeh Abedini; Arda Kiani; Mehdi Mirsaeidi; Dina Soroush; Johan Garssen; Aliakbar Velayati; Frank A Redegeld; Ian M Adcock
Journal:  J Inflamm (Lond)       Date:  2015-03-19       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.